These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21204911)

  • 1. Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study.
    Ruokoniemi P; Korhonen MJ; Helin-Salmivaara A; Lavikainen P; Jula A; Junnila SY; Kettunen R; Huupponen R
    Br J Clin Pharmacol; 2011 May; 71(5):766-76. PubMed ID: 21204911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to statin therapy and the incidence of ischemic stroke in patients with diabetes.
    Korhonen MJ; Ruokoniemi P; Ilomäki J; Meretoja A; Helin-Salmivaara A; Huupponen R
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):161-9. PubMed ID: 26687512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.
    Serban MC; Colantonio LD; Manthripragada AD; Monda KL; Bittner VA; Banach M; Chen L; Huang L; Dent R; Kent ST; Muntner P; Rosenson RS
    J Am Coll Cardiol; 2017 Mar; 69(11):1386-1395. PubMed ID: 28302290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of better adherence to statin agents in the primary prevention of coronary artery disease.
    Perreault S; Dragomir A; Blais L; Bérard A; Lalonde L; White M; Pilon D
    Eur J Clin Pharmacol; 2009 Oct; 65(10):1013-24. PubMed ID: 19529927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin usage and all-cause and disease-specific mortality in a nationwide study.
    Haukka J; Niskanen L; Partonen T; Lönnqvist J; Tiihonen J
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):61-9. PubMed ID: 21956915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes.
    Xie G; Sun Y; Myint PK; Patel A; Yang X; Li M; Li X; Wu T; Li S; Gao R; Wu Y
    Lipids Health Dis; 2017 Aug; 16(1):155. PubMed ID: 28810873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins, risk of diabetes, and implications on outcomes in the general population.
    Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen SJ; Chen TJ; Lin SJ; Chiang CE
    J Am Coll Cardiol; 2012 Oct; 60(14):1231-8. PubMed ID: 22884288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.
    Rosenson RS; Kent ST; Brown TM; Farkouh ME; Levitan EB; Yun H; Sharma P; Safford MM; Kilgore M; Muntner P; Bittner V
    J Am Coll Cardiol; 2015 Jan; 65(3):270-7. PubMed ID: 25614424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
    Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
    Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence.
    Lavikainen P; Helin-Salmivaara A; Eerola M; Fang G; Hartikainen J; Huupponen R; Korhonen MJ
    BMJ Open; 2016 Jun; 6(6):e011306. PubMed ID: 27259530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of statins after hospitalization for coronary heart disease.
    Ye X; Gross CR; Schommer J; Cline R; Xuan J; St Peter WL
    J Manag Care Pharm; 2007 Jun; 13(5):385-96. PubMed ID: 17605510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins.
    Wei WQ; Li X; Feng Q; Kubo M; Kullo IJ; Peissig PL; Karlson EW; Jarvik GP; Lee MTM; Shang N; Larson EA; Edwards T; Shaffer CM; Mosley JD; Maeda S; Horikoshi M; Ritchie M; Williams MS; Larson EB; Crosslin DR; Bland HT; Pacheco JA; Rasmussen-Torvik LJ; Cronkite D; Hripcsak G; Cox NJ; Wilke RA; Stein CM; Rotter JI; Momozawa Y; Roden DM; Krauss RM; Denny JC
    Circulation; 2018 Oct; 138(17):1839-1849. PubMed ID: 29703846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study.
    Poluzzi E; Piccinni C; Carta P; Puccini A; Lanzoni M; Motola D; Vaccheri A; De Ponti F; Montanaro N
    Eur J Clin Pharmacol; 2011 Apr; 67(4):407-414. PubMed ID: 21152908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Register-based predictors of adherence among new statin users in Finland.
    Aarnio EJ; Martikainen JA; Helin-Salmivaara A; Huupponen RK; Hartikainen JE; Peura PK; Korhonen MJ
    J Clin Lipidol; 2014; 8(1):117-25. PubMed ID: 24528692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.
    Colantonio LD; Huang L; Monda KL; Bittner V; Serban MC; Taylor B; Brown TM; Glasser SP; Muntner P; Rosenson RS
    JAMA Cardiol; 2017 Aug; 2(8):890-895. PubMed ID: 28423147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk.
    Lin I; Sung J; Sanchez RJ; Mallya UG; Friedman M; Panaccio M; Koren A; Neumann P; Menzin J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):685-98. PubMed ID: 27231796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.